Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Erica Bickerton

19PUBLICATIONS

35CO-AUTHORS

Animal protection (incl. pests and pathogens)Radiation therapyDeep learningMedical devicesMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Feb 27, 2025

Recombinant infectious bronchitis virus containing mutations in non-structural proteins 10, 14, 15, and 16 and within the macrodomain provides complete protection against homologous challenge.

Sarah Keep, Katalin Foldes, Guilia Dowgier

|Jan 24, 2024

The spike protein of the apathogenic Beaudette strain of avian coronavirus can elicit a protective immune response against a virulent M41 challenge.

Sarah Keep, Phoebe Stevenson-Leggett, Isobel Webb

|Nov 25, 2023

Revealing Novel-Strain-Specific and Shared Epitopes of Infectious Bronchitis Virus Spike Glycoprotein Using Chemical Linkage of Peptides onto Scaffolds Precision Epitope Mapping.

Samantha Sives, Sarah Keep, Erica Bickerton

|Feb 13, 2023

Deletion of the s2m RNA Structure in the Avian Coronavirus Infectious Bronchitis Virus and Human Astrovirus Results in Sequence Insertions.

Sarah Keep, Giulia Dowgier, Valeria Lulla

|Dec 21, 2022

Virus Detection and Identification in Minutes Using Single-Particle Imaging and Deep Learning.

Nicolas Shiaelis, Alexander Tometzki, Leon Peto

|Aug 26, 2022

The Genetic Stability, Replication Kinetics and Cytopathogenicity of Recombinant Avian Coronaviruses with a T16A or an A26F Mutation within the E Protein Is Cell-Type Dependent.

Isobel Webb, Sarah Keep, Kieran Littolff

Pageof 4

Frequent Collaborators

8 joint publications

Sarah Keep

3 joint publications

Helena J Maier

3 joint publications

Lonneke Vervelde

3 joint publications

Phoebe Stevenson-Leggett

2 joint publications

Samantha Sives

1 joint publications

Andrew E Firth

1 joint publications

Nazia Thakur

1 joint publications

Stacey Human

1 joint publications

James T Kelly

1 joint publications

Sushant Bhat

Frequent Collaborators

8 joint publications

Sarah Keep

3 joint publications

Helena J Maier

3 joint publications

Lonneke Vervelde

3 joint publications

Phoebe Stevenson-Leggett

Top Related Videos

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on : May 06, 2015

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on : May 02, 2011

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

See more related videos

Top Related Videos

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on : May 06, 2015

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on : May 02, 2011

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

See more related videos